Gritstone Oncology GRTS

$ 2.39 0.42%

Quarterly report 2024-Q2
added 08-13-2024

Gritstone Oncology Balance Sheet 2011-2024 | GRTS

Annual Balance Sheet Gritstone Oncology

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-15.9 M	-30.9 M	-84.2 M	-	-33.9 M	-41.7 M	-28.5 M	-12.4 M	-	-	-	-	-
Long Term Debt	40.1 M	19.3 M	18.9 M	-	-	-	-	-	-	-	-	-	-
Long Term Debt Current	6.9 M	5.29 M	7.48 M	5.87 M	2.5 M	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	30.5 M	25.3 M	12.4 M	2.24 M	-	-	-	-	-
Total Current Liabilities	27.3 M	34.8 M	40 M	27 M	19.5 M	15.1 M	-	-	-	-	-	-	-
Total Liabilities	126 M	70 M	62 M	54.8 M	50 M	40.4 M	20 M	4.73 M	-	-	-	-	-
Deferred Revenue	2.35 M	5.13 M	17.2 M	3.48 M	4.96 M	5.34 M	-	-	-	-	-	-	-
Retained Earnings	-660 M	-521 M	-401 M	-326 M	-221 M	-126 M	-61.6 M	-20.2 M	-	-	-	-	-
Total Assets	178 M	241 M	278 M	222 M	184 M	190 M	117 M	46.4 M	-	-	-	-	-
Cash and Cash Equivalents	63 M	55.5 M	111 M	171 M	57.4 M	52.2 M	40 M	12.4 M	-	-	-	-	-
Book Value	51.8 M	171 M	216 M	167 M	134 M	149 M	97.3 M	41.7 M	-	-	-	-	-
Total Shareholders Equity	51.8 M	171 M	216 M	167 M	134 M	149 M	97.3 M	41.7 M	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet Gritstone Oncology

	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	40.5 M	40.3 M	40.1 M	29.9 M	29.7 M	-	19.3 M	19.3 M	-	18.7 M	18.9 M	19.8 M	16.2 M	17.6 M	19.2 M	19.2 M	19.2 M	19.2 M	-	21 M	21 M	21 M	10.5 M	10.5 M	10.5 M	10.5 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	120 M	123 M	126 M	113 M	113 M	-	70 M	68.4 M	-	54.3 M	62 M	63.3 M	45.4 M	47.6 M	54.8 M	54.8 M	54.8 M	54.8 M	50 M	50 M	50 M	50 M	40.4 M	40.4 M	40.4 M	40.4 M	20 M	20 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	698 K	1.28 M	2.35 M	1.3 M	2.82 M	-	5.13 M	8.69 M	-	12.3 M	17.2 M	13.8 M	2.94 M	3.39 M	3.48 M	3.48 M	3.48 M	3.48 M	4.96 M	4.96 M	4.96 M	4.96 M	5.34 M	5.21 M	5.34 M	5.34 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-723 M	-700 M	-660 M	-629 M	-590 M	-	-521 M	-490 M	-	-430 M	-401 M	-372 M	-343 M	-318 M	-326 M	-326 M	-326 M	-326 M	-221 M	-221 M	-221 M	-221 M	-126 M	-126 M	-126 M	-126 M	-61.6 M	-61.6 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	143 M	137 M	178 M	187 M	223 M	-	241 M	205 M	-	243 M	278 M	271 M	224 M	247 M	222 M	222 M	222 M	222 M	184 M	184 M	184 M	184 M	190 M	190 M	190 M	190 M	117 M	117 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	50.9 M	42.4 M	63 M	29.5 M	49.1 M	54.5 M	55.5 M	76.9 M	80.3 M	69.2 M	93.3 M	148 M	64.1 M	109 M	170 M	170 M	170 M	170 M	57.4 M	57.4 M	57.4 M	57.4 M	52.2 M	52.2 M	52.2 M	52.2 M	39 M	39 M	-	-	12.4 M	-	-	-	23.9 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	22.2 M	14 M	51.8 M	74 M	110 M	-	171 M	137 M	-	189 M	216 M	208 M	179 M	199 M	167 M	167 M	167 M	167 M	134 M	134 M	134 M	134 M	149 M	149 M	149 M	149 M	97.3 M	97.3 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	22.2 M	14 M	51.8 M	74 M	110 M	141 M	171 M	137 M	163 M	189 M	216 M	208 M	179 M	199 M	167 M	167 M	167 M	167 M	134 M	134 M	134 M	134 M	149 M	149 M	149 M	149 M	97.3 M	97.3 M	-	-	41.7 M	-	-	-	24 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency